XERS Competitors & Alternatives

Compare Xeris Pharmaceuticals Inc with similar stocks in the same industry

Drug Manufacturers - Specialty & Generic

XERS

Main Stock
$8.28
Tradestie Score
61
Market Cap
$1.29B
P/E Ratio
119.1
Revenue Growth
0.4%
Analyst Upside
+36.3%

Top Competitors

46 stocks in Drug Manufacturers - Specialty & Generic
Company Price Market Cap P/E Score Action
PAHC Phibro Animal Health Corporation Class A
$33.04
$1.65B 13.8 54 Compare
BCRX BioCryst Pharmaceuticals Inc
$9.74
$1.55B - 51 Compare
AMLX Amylyx Pharmaceuticals, Inc. Common Stock
$18.20
$1.49B - 57 Compare
AVDL Avadel Pharmaceuticals plc Ordinary Share
$21.64
$1.46B - 62 Compare
EVO Evotec SE American Depositary Shares
$2.14
$1.34B - 40 Compare
ARDX Ardelyx, Inc.
$5.16
$1.29B - 54 Compare
AMPH Amphastar Pharmaceuticals, Inc.
$18.81
$1.25B 11.3 55 Compare
DVAX Dynavax Technologies Corporation
$15.50
$1.21B - 55 Compare
PCRX Pacira BioSciences, Inc. Common Stock
$25.01
$1.14B 196.0 57 Compare
COLL Collegium Pharmaceutical, Inc. Common Stock
$35.02
$1.11B 17.1 54 Compare

Data updated: Jul 15, 2026 | Industry: Drug Manufacturers - Specialty & Generic (SIC 2834)

46 stocks in this industry